SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products.

GLP Compliant Laboratory

Skin Sensitizing Hazard

GARD®skin and GARD®skin Medical Device are robust in vitro tests to identify potential chemical skin sensitizers with broad applicability and over 90% prediction accuracy.

Skin Sensitizing Potency

GARD®skin Dose-Response and GARD®potency are robust in vitro tests for qualitative and quatantative skin sensitizing potency assessment.

Respiratory Sensitization

GARD®air is the only commercially available in vitro test capable of identifying chemical respiratory sensitizers. The test is recommended for use as an R&D tool.

Press Releases

20 Aug, 2020
News
IR
English
Regulatory
MAR
Report
Interim
Q2
13 Aug, 2020
News
IR
English
Corporate Information
Presentation
09 Jul, 2020
News
IR
English
Corporate Information
Other Corporate Information

Subscribe


Prenumerera